Prognostic significance of the neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small-cell lung cancer

por Rapoport, Bernardo L, Theron, Annette J, Vorobiof, Daniel A, Langenhoven, Lizanne, Hall, Jacqueline M, Van Eeden, Ronwyn I, Smit, Teresa, Chan, Sze-Wai, Botha, Michael C, Raats, Johann I, Necker, Margriet De, Anderson, Ronald
Publicado 2020